You evidently know very little about legal consequences. Every list stock carries insurance for gratuitous law suits and legal expenses are insignificant. No assurances were made, nor could be implied in a phase II study asking for acceleration by the FDA.
Class action suits against pharmas are like woodworms with heads perked and rotating, looking for food. Learn a little something.